Literature DB >> 10674761

Application of 2,3,5-triphenyltetrazolium chloride staining to evaluate injury volume after controlled cortical impact brain injury: role of brain edema in evolution of injury volume.

M K Başkaya1, A Doğan, C Temiz, R J Dempsey.   

Abstract

A reliable method for measuring injury volume after traumatic brain injury (TBI) is of great importance when studying pharmacological protective agents in the field of head trauma research. Utilization of 2,3,5-triphenyltetrazolium chloride (TTC) has gained extensive acceptance in stroke research and has recently been applied to injury volume measurement in the lateral fluid percussion model. The present study was undertaken to apply this method to the controlled cortical impact (CCI) model and to study the role of brain edema. Male Sprague-Dawley rats were subjected to CCI brain injury at a velocity of 3 m/sec and 1 mm (mild), 2 mm (moderate), and 3 mm (severe injury) deformation, while rats in the control group were subjected to the same surgical procedure but received no injury. Absolute and corrected injury volumes with TTC staining and brain edema measurements with the wet-dry method were evaluated at 1, 2, 3, 4, and 7 days after TBI. The most prominent injury volume in the moderate injury group (2 mm deformation) was seen at postinjury day 1 and 2 (day 1, absolute: 49.1+/-5.6, corrected: 40.5+/-7.9; day 2, absolute: 46+/-6.9, corrected: 40.2+/-10.5), whereas the smallest injury volume was found at postinjury day 7 (absolute: 24.9+/-7, corrected: 27.4+/-7.4). The time course of brain edema studies demonstrates that brain edema formation peaks at postinjury day 1. A statistically significant reduction of injury volume was observed after postinjury day 4. We also observed that due to the presence of brain edema absolute injury volume is more than corrected injury volume in the first 3 days after injury as opposed to injury volume at postinjury day 7. These results suggest that the measurement of injury volume with TTC staining should be corrected for brain edema in the CCI brain injury model.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10674761     DOI: 10.1089/neu.2000.17.93

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  9 in total

1.  PET imaging of neuroinflammation in a rat traumatic brain injury model with radiolabeled TSPO ligand DPA-714.

Authors:  Yu Wang; Xuyi Yue; Dale O Kiesewetter; Gang Niu; Gaojun Teng; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-11       Impact factor: 9.236

2.  Experimental traumatic brain injury.

Authors:  Christiane Albert-Weissenberger; Anna-Leena Sirén
Journal:  Exp Transl Stroke Med       Date:  2010-08-13

Review 3.  Evidence to support mitochondrial neuroprotection, in severe traumatic brain injury.

Authors:  Shyam Gajavelli; Vishal K Sinha; Anna T Mazzeo; Markus S Spurlock; Stephanie W Lee; Aminul I Ahmed; Shoji Yokobori; Ross M Bullock
Journal:  J Bioenerg Biomembr       Date:  2014-10-31       Impact factor: 2.945

4.  Neuroprotective effect of ginseng total saponins in experimental traumatic brain injury.

Authors:  Yong Cheol Ji; Young Baeg Kim; Seung Won Park; Sung Nam Hwang; Byung Kook Min; Hyun Jong Hong; Jeong Taik Kwon; Jong Sik Suk
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

5.  Mass Spectrometric Imaging of Ceramide Biomarkers Tracks Therapeutic Response in Traumatic Brain Injury.

Authors:  Damon C Barbacci; Aurelie Roux; Ludovic Muller; Shelley N Jackson; Jeremy Post; Kathrine Baldwin; Barry Hoffer; Carey D Balaban; J Albert Schultz; Shawn Gouty; Brian M Cox; Amina S Woods
Journal:  ACS Chem Neurosci       Date:  2017-08-14       Impact factor: 4.418

6.  Facilitated assessment of tissue loss following traumatic brain injury.

Authors:  Anders Hånell; Johanna Hedin; Fredrik Clausen; Niklas Marklund
Journal:  Front Neurol       Date:  2012-03-14       Impact factor: 4.003

7.  Preservation of the blood brain barrier and cortical neuronal tissue by liraglutide, a long acting glucagon-like-1 analogue, after experimental traumatic brain injury.

Authors:  Jakob Hakon; Karsten Ruscher; Bertil Romner; Gregor Tomasevic
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

8.  Lesion Index Titration Using Contact-Force Technology Enables Safe and Effective Radiofrequency Lesion Creation at the Root of the Aorta and Pulmonary Artery.

Authors:  José Manuel Alfonso-Almazán; Jorge G Quintanilla; María Jesús García-Torrent; Santiago Laguna-Castro; Cruz Rodríguez-Bobada; Pablo González; Juan José González-Ferrer; Pablo Salinas; Victoria Cañadas-Godoy; Javier Moreno; Luis Borrego-Bernabé; Nicasio Pérez-Castellano; José Jalife; Julián Perez-Villacastín; David Filgueiras-Rama
Journal:  Circ Arrhythm Electrophysiol       Date:  2019-03

9.  Chronic Administration of 7,8-DHF Lessens the Depression-like Behavior of Juvenile Mild Traumatic Brain Injury Treated Rats at Their Adult Age.

Authors:  Shih-Te Yang; Hsiu-Yi Hung; Long-Sun Ro; Ming-Feng Liao; Tamara G Amstislavskaya; Maria A Tikhonova; Yi-Ling Yang; Kwok-Tung Lu
Journal:  Pharmaceutics       Date:  2021-12-16       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.